120 related articles for article (PubMed ID: 8059535)
1. Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
Howell SR; Hicks DR; Scatina JA; Sisenwine SF
Xenobiotica; 1994 Apr; 24(4):315-27. PubMed ID: 8059535
[TBL] [Abstract][Full Text] [Related]
2. The effect of renal disease on the disposition of venlafaxine.
Troy SM; Schultz RW; Parker VD; Chiang ST; Blum RA
Clin Pharmacol Ther; 1994 Jul; 56(1):14-21. PubMed ID: 8033490
[TBL] [Abstract][Full Text] [Related]
3. Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man.
Howell SR; Husbands GE; Scatina JA; Sisenwine SF
Xenobiotica; 1993 Apr; 23(4):349-59. PubMed ID: 8337893
[TBL] [Abstract][Full Text] [Related]
4. Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics.
Klamerus KJ; Parker VD; Rudolph RL; Derivan AT; Chiang ST
Pharmacotherapy; 1996; 16(5):915-23. PubMed ID: 8888087
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
Troy SM; Parker VD; Fruncillo RJ; Chiang ST
J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
[TBL] [Abstract][Full Text] [Related]
6. Phenolic esters of O-desmethylvenlafaxine with improved oral bioavailability and brain uptake.
Zhang Y; Yang Y; Zhao S; Yang Z; Yang H; Fawcett JP; Li Y; Gu J; Sun T
Molecules; 2013 Dec; 18(12):14920-34. PubMed ID: 24304586
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
[TBL] [Abstract][Full Text] [Related]
8. Effect Of Chinese Herb Danzhi Xiaoyao Pills On Pharmacokinetics Of Venlafaxine In Beagles.
Zhu YL; Li SL; Chen KL; Ma KP; Wu DQ; Qiu XJ
Drug Des Devel Ther; 2019; 13():3343-3355. PubMed ID: 31571835
[TBL] [Abstract][Full Text] [Related]
9. A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids.
Hicks DR; Wolaniuk D; Russell A; Cavanaugh N; Kraml M
Ther Drug Monit; 1994 Feb; 16(1):100-7. PubMed ID: 8160247
[TBL] [Abstract][Full Text] [Related]
10. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
Troy SM; Parker VD; Hicks DR; Boudino FD; Chiang ST
J Clin Pharmacol; 1996 Feb; 36(2):175-81. PubMed ID: 8852394
[TBL] [Abstract][Full Text] [Related]
12. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite.
Klamerus KJ; Maloney K; Rudolph RL; Sisenwine SF; Jusko WJ; Chiang ST
J Clin Pharmacol; 1992 Aug; 32(8):716-24. PubMed ID: 1487561
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
Newport DJ; Ritchie JC; Knight BT; Glover BA; Zach EB; Stowe ZN
J Clin Psychiatry; 2009 Sep; 70(9):1304-10. PubMed ID: 19607765
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
15. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Murrell MD; Cruz DA; Javors MA; Thompson PM
J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
[TBL] [Abstract][Full Text] [Related]
16. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
[TBL] [Abstract][Full Text] [Related]
17. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
[TBL] [Abstract][Full Text] [Related]
18. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
19. Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.
Waschgler R; Moll W; König P; Conca A
Int J Clin Pharmacol Ther; 2004 Dec; 42(12):724-8. PubMed ID: 15624289
[TBL] [Abstract][Full Text] [Related]
20. Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G
Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
